Cullen/Frost Bankers’s Virtus Biotech ETF BBP Stock Holding History

Cullen/Frost Bankers’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-70	Closed	-$4K	–	1207
2021 Q2	$4K	Hold	70	–	–	﹤0.01%	1124
2021 Q1	$4K	Hold	70	–	–	﹤0.01%	992
2020 Q4	$4K	Hold	70	–	–	﹤0.01%	960
2020 Q3	$3K	Hold	70	–	–	﹤0.01%	991
2020 Q2	$3K	Hold	70	–	–	﹤0.01%	994
2020 Q1	$3K	Hold	70	–	–	﹤0.01%	826
2019 Q4	$3K	Hold	70	–	–	﹤0.01%	973
2019 Q3	$3K	Hold	70	–	–	﹤0.01%	943
2019 Q2	$3K	Hold	70	–	–	﹤0.01%	944
2019 Q1	$3K	Buy	+70	New	+$2.93K	﹤0.01%	829

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SMG

Smart Money Group Eastland, Texas $344M AUM 16.66% 1-Year Est. Return

FAIM

Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cullen/Frost Bankers's BBP Position: Q3 2021 in Review

Cullen/Frost Bankers sold out of Virtus Biotech ETF (BBP) in Q3 2021, closing a stake of 70 shares — an estimated $4K sold.

Cullen/Frost Bankers first reported a position in BBP in Q1 2019 and held it in 10 quarters. The position peaked at $4K in Q2 2021. 13 funds tracked by Wall St. Rank hold BBP as of Q3 2021.

Cullen/Frost Bankers reported no remaining Virtus Biotech ETF position as of Q3 2021 after selling out during the quarter.
Cullen/Frost Bankers sold 70 Virtus Biotech ETF shares in Q3 2021, an estimated $4K.
Cullen/Frost Bankers first reported a position in Virtus Biotech ETF in Q1 2019 and held it in 10 quarters.
Cullen/Frost Bankers's Virtus Biotech ETF position peaked at $4K in Q2 2021.
13 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2021.

Based on Cullen/Frost Bankers's 13F filing for Q3 2021, filed 4 Nov 2021.